Overview

There has been a significant improvement in the quality of clinical research performed in the field of neuromodulation over the last 40 years. Simple observational and retrospective studies have largely been replaced with prospective, randomized trials as the current level of medical evidence demands. That being said, recently published studies continue to have multiple significant biases, suboptimal outcomes assessments and lack sufficient follow-up. This has been the focus of much recently published research and expert research recommendations. Those in the field of neuromodulation involved in the design or execution of future studies need to be aware of these issues and recommendations. Furthermore, neuromodulation practitioners need to be aware of these issues and recommendations to be able to properly assess the design and quality of execution of these important future studies

Program

Moderators: Kiran Patel, MD and Christopher Gilligan, MD, MBA
Topics and Faculty 1.) Large Group Practice- Sean Li, MD, FIPP
2.) Independent Practice- Jason Pope, MD
3.) Academic Practice- Christopher Gilligan, MD, MBA